Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-24

Clinical Trial Update: Drug-drug Interaction Study of ZT002 Injection in Overweight and Obese Participants [Phase 1]

View source ↗

Summary

This is a Phase 1 drug-drug interaction study of ZT002 injection in overweight and obese participants. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZT002 Injection

Snippet

Sponsor: Beijing QL Biopharmaceutical Co.,Ltd | Conditions: Overweight,Obesity | Phase 1 | Status: NOT_YET_RECRUITING